DENMARK: DermaOxy, a subsidiary of Danish medical company MedicTinedic ApS, is looking to expand to the US market, and is seeking strategic partners to launch several new skin care products. New products include oxygen concentrators, anti-aging serums, hair tonics, and rejuvenating lotions intended for American beauty clinics and aestheticians.
Founded in 2009 with the goal to provide complete nonsurgical oxygen treatments and skin products, DermaOxy oxygen treatments involve pressing oxygen deep under the skin to revitalize deep layers of skin and hair cells. Treatment instruments include airbrushes and the “in2OXY” pen. The anti-aging serums use a small patented peptide called SYN-Coll to increase the amount of moisture in the skin and optimize the elasticity of the skin, giving a more youthful appearance.